It's great that HEMA was able to team up with Charles River to compete with AllCells in China. It would be interesting to know how the medical research community views one company's products and services versus the other.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.